Study on the Diagnosis of Small Hepatocellular Carcinoma Caused by Hepatitis B Cirrhosis Via Multi-slice Spiral CT and MRI

Overview

Journal Oncol Lett

Specialty Oncology

Date 2018 Jan 30

PMID 29375718

Citations 6

Authors

Mei Wang

Congxin Wei

Zhaojuan Shi

Jianzhong Zhu

Affiliations

Soon will be listed here.

Abstract

The present study compared the diagnostic accuracy of multi-slice spiral computed tomography (CT) and magnetic resonance imaging (MRI) on small hepatocellular carcinoma (SHCC) caused by hepatitis B cirrhosis. A total of 160 patients with hepatitis B cirrhosis were selected between January 2012 and April 2016, and 183 SHCC lesions were included in the present retrospective study. Patients were divided into the SHCC group (T stage) and the micro hepatocellular carcinoma (MHCC) group (T1 stage). There were a total of 129 SHCC lesions and 54 MHCC lesions identified. All patients underwent multiphasic CT and MRI imaging. The liver acquisition with volume acquisition (LAVA) technique was utilized for MRI. Furthermore, SPSS 20.0 was used for statistical analyses. LAVA in the arterial phase and CT in the arterial phase revealed significantly higher diagnostic rates for the diagnoses of 183 lesions. In addition, standard CT scan exhibited significantly reduced diagnostic rates in SHCC lesions. Results indicated that LAVA in the equilibrium phase had the lowest diagnostic rate in MHCC lesions, which was statistically significant (P<0.05). Overall, the diagnostic rate of CT (79.63%) for MHCC was significantly lower than that of MRI (96.29%) (P<0.05). However, the diagnostic rate of CT for SHCC (96.12%) was significantly higher than that for MHCC (79.63%) (P<0.05). MRI-LAVA in the arterial phase has the highest diagnostic rate for SHCC and MHCC. However, the diagnostic capability of MRI for MHCC lesions is superior to that of CT.

Citing Articles

The Value of CT Perfusion Parameters and Apparent Diffusion Coefficient Value of Magnetic Resonance Diffusion Weighted Imaging in Diagnosis of Hepatocellular Carcinoma.

Li K, Wang B Comput Math Methods Med. 2022; 2022:2771869.

PMID: 36203535 PMC: 9532146. DOI: 10.1155/2022/2771869.

Clinical value of contrast-enhanced ultrasound in early diagnosis of small hepatocellular carcinoma (≤ 2 cm).

Mei Q, Yu M, Chen Q World J Clin Cases. 2022; 10(24):8525-8534.

PMID: 36157793 PMC: 9453369. DOI: 10.12998/wjcc.v10.i24.8525.

Application of Endoscopic Ultrasound Combined with Multislice Spiral CT in Diagnosis and Treatment of Patients with Gastrointestinal Eminence Lesions.

Xiong J, Jiang J, Chen Y, Chen Y, Xie C, Xu S Dis Markers. 2022; 2022:1417104.

PMID: 35811661 PMC: 9259227. DOI: 10.1155/2022/1417104.

Research on the Construction of Bispecific-Targeted Sustained-Release Drug-Delivery Microspheres and Their Function in Treatment of Hepatocellular Carcinoma.

Huang Z, Li F, Zhang J, Shi X, Xu Y, Huang X ACS Omega. 2022; 7(25):22003-22014.

PMID: 35785307 PMC: 9244910. DOI: 10.1021/acsomega.2c02584.

Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Nadarevic T, Giljaca V, Colli A, Fraquelli M, Casazza G, Miletic D Cochrane Database Syst Rev. 2021; 10:CD013362.

PMID: 34611889 PMC: 8493329. DOI: 10.1002/14651858.CD013362.pub2.

References

Wang R, Luo Y, Yang S, Lin J, Gao D, Zhao Y . Hyaluronic acid-modified manganese-chelated dendrimer-entrapped gold nanoparticles for the targeted CT/MR dual-mode imaging of hepatocellular carcinoma. Sci Rep. 2016; 6:33844. PMC: 5032118. DOI: 10.1038/srep33844. View

Bruix J, Gores G, Mazzaferro V . Hepatocellular carcinoma: clinical frontiers and perspectives. Gut. 2014; 63(5):844-55. PMC: 4337888. DOI: 10.1136/gutjnl-2013-306627. View

Chou C, Chen R, Lin W, Ko C, Chen C, Chen Y . Prediction of microvascular invasion of hepatocellular carcinoma: preoperative CT and histopathologic correlation. AJR Am J Roentgenol. 2014; 203(3):W253-9. DOI: 10.2214/AJR.13.10595. View

Wang Y, Luo Q, Li Y, Deng S, Wei S, Li X . Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a meta-analysis of randomized and nonrandomized controlled trials. PLoS One. 2014; 9(1):e84484. PMC: 3880302. DOI: 10.1371/journal.pone.0084484. View

Sattler B, Lee J, Lonsdale M, Coche E . PET/CT (and CT) instrumentation, image reconstruction and data transfer for radiotherapy planning. Radiother Oncol. 2010; 96(3):288-97. DOI: 10.1016/j.radonc.2010.07.009. View

Kim J, Kwon C, Joh J, Park J, Lee J, Kim S . Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis. Ann Surg Oncol. 2013; 21(2):458-65. DOI: 10.1245/s10434-013-3302-1. View

Hagel M, Miduturu C, Sheets M, Rubin N, Weng W, Stransky N . First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway. Cancer Discov. 2015; 5(4):424-37. DOI: 10.1158/2159-8290.CD-14-1029. View

Cicciu M, Herford A, Cervino G, Troiano G, Lauritano F, Laino L . Tissue Fluorescence Imaging (VELscope) for Quick Non-Invasive Diagnosis in Oral Pathology. J Craniofac Surg. 2016; 28(2):e112-e115. DOI: 10.1097/SCS.0000000000003210. View

Hong Y, Yoon K, Cho M, Heo J, Woo H, Lim W . A case of small hepatocellular carcinoma with an extensive lymph node metastasis at diagnosis. Clin Mol Hepatol. 2014; 20(3):310-2. PMC: 4197181. DOI: 10.3350/cmh.2014.20.3.310. View

10.

Banaudha K, Verma M . Epigenetic biomarkers in liver cancer. Methods Mol Biol. 2014; 1238:65-76. DOI: 10.1007/978-1-4939-1804-1_4. View

11.

Fitzmorris P, Shoreibah M, Anand B, Singal A . Management of hepatocellular carcinoma. J Cancer Res Clin Oncol. 2014; 141(5):861-76. DOI: 10.1007/s00432-014-1806-0. View

12.

Wang Y, Gao Y, Shi W, Zhai D, Rao Q, Jia X . Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma. Cancer Biomark. 2014; 15(2):171-80. DOI: 10.3233/CBM-140451. View

13.

Sahinarslan A, Erbas G, Kocaman S, Bas D, Akyel A, Karaer D . Comparison of radiation-induced damage between CT angiography and conventional coronary angiography. Acta Cardiol. 2013; 68(3):291-7. DOI: 10.1080/ac.68.3.2983424. View

14.

Lv P, Lin X, Li J, Li W, Chen K . Differentiation of small hepatic hemangioma from small hepatocellular carcinoma: recently introduced spectral CT method. Radiology. 2011; 259(3):720-9. DOI: 10.1148/radiol.11101425. View

15.

Yu M, Kim J, Yoon J, Kim H, Chung J, Han J . Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging. Radiology. 2014; 271(3):748-60. DOI: 10.1148/radiol.14131996. View

16.

Zhao X, Li W, Chai W, Chen K . Detection of small hepatocellular carcinoma using gadoxetic acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial?. J Dig Dis. 2013; 15(3):137-45. DOI: 10.1111/1751-2980.12119. View

17.

Jiang Y, Wang X, Guo X, Jiang X . [Small hepatocellular carcinoma in patients with hepatitis B-induced cirrhosis: a comparison between MRI and MDCT]. Beijing Da Xue Xue Bao Yi Xue Ban. 2010; 42(6):767-72. View

18.

Hartke J, Johnson M, Ghabril M . The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol. 2017; 34(2):153-159. DOI: 10.1053/j.semdp.2016.12.011. View

19.

Thakral S, Ghoshal K . miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir. Curr Gene Ther. 2014; 15(2):142-50. PMC: 4439190. DOI: 10.2174/1566523214666141224095610. View

20.

Schiebler M, Bhalla S, Runo J, Jarjour N, Roldan A, Chesler N . Magnetic resonance and computed tomography imaging of the structural and functional changes of pulmonary arterial hypertension. J Thorac Imaging. 2013; 28(3):178-93. PMC: 3903366. DOI: 10.1097/RTI.0b013e31828d5c48. View